| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Catecholamine physiology and its implications in patients with COVID-19
|
Gubbi, Sriram
|
|
|
8 |
12 |
p. 978-986
|
artikel
|
| 2 |
Changing faces: the history of diabetes and race
|
Thorley, Jennifer
|
|
|
8 |
12 |
p. 936
|
artikel
|
| 3 |
Correction to Lancet Diabetes Endocrinol 2020; 8: 939–48
|
|
|
|
8 |
12 |
p. e7
|
artikel
|
| 4 |
Correction to Lancet Diabetes Endocrinol 2016; 4: 732–33
|
|
|
|
8 |
12 |
p. e7
|
artikel
|
| 5 |
Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial
|
McGuire, Darren K
|
|
|
8 |
12 |
p. 949-959
|
artikel
|
| 6 |
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
|
Clément, Karine
|
|
|
8 |
12 |
p. 960-970
|
artikel
|
| 7 |
EMPA-REG OUTCOME and beyond: the long game of cardiovascular risk reduction
|
Aroda, Vanita R
|
|
|
8 |
12 |
p. 932-933
|
artikel
|
| 8 |
Insulin's centenary: the birth of an idea
|
Hegele, Robert A
|
|
|
8 |
12 |
p. 971-977
|
artikel
|
| 9 |
Metabolic health in Brazil: trends and challenges
|
Cohen, Ricardo V
|
|
|
8 |
12 |
p. 937-938
|
artikel
|
| 10 |
Nurses: at the heart of diabetes care
|
The Lancet Diabetes & Endocrinology,
|
|
|
8 |
12 |
p. 931
|
artikel
|
| 11 |
Setmelanotide: what does it mean for clinical care of patients with obesity?
|
Ryan, Donna H
|
|
|
8 |
12 |
p. 933-935
|
artikel
|
| 12 |
2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial
|
Al-Mrabeh, Ahmad
|
|
|
8 |
12 |
p. 939-948
|
artikel
|
Tijdschrift beschrijving